Sep 07, 2023 / 03:00PM GMT
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
Good morning. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. It's my pleasure to host this session with the management team from Edwards Lifesciences. With us, we have Bernard Zovighian, the new CEO; and Scott Ullem, the CFO. Terms of format, it's going to be a fireside chat. If anybody has a question, just raise your hand. We'll come around with the mic. Bernard and Scott, thanks so much for being here.
Bernard J. Zovighian - Edwards Lifesciences Corporation - CEO & Director
My pleasure. Thank you.
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
Kevin, can you please start the clock? Thank you. All right. So let's jump in. Bernard, you recently became CEO. My question is, do you foresee any changes to the strategy going forward? Under Mike Mussallem, the company is very focused on innovation, structural heart
Edwards Lifesciences Corp at Wells Fargo Healthcare Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers